Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
D. Guerra, T. Beaumont, L. Radic…·M. J. van Gils
This study identifies broadly neutralizing monoclonal and bispecific antibodies from a Gamma variant-infected individual that effectively neutralize multiple SARS-CoV-2 variants.
D. M. H. van Rijswijck, A. Bondt, M. Hoek…·A. J. R. Heck
The paper analyzes IgG1 clonal responses to SARS-CoV-2 variants in infected donors, finding unique and polyclonal antibody repertoires with varying cross-reactivity across variants.
M. Claireaux, T. G. Caniels, M. de Gast…·M. J. van Gils
The paper identifies a novel S2 epitope recognized by a public antibody class in SARS-CoV-2-reactive B cells, which becomes exposed on vaccine-optimized spike proteins.
P. J. M. Brouwer, M. Brinkkemper, P. Maisonnasse…·de Bree
This paper develops a two-component spike nanoparticle vaccine that protects macaques from SARS-CoV-2 infection by inducing strong neutralizing antibodies and reducing viral replication.
W. Hoepel, H.-J. Chen, S. Allahverdiyeva…·J. den Dunnen
Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients induces hyper-inflammatory responses in macrophages, leading to endothelial barrier breakdown and microvascular thrombosis.